Bristol-Myers Squibb Company (BMY)
NYSE: BMY · Real-Time Price · USD
62.56
+0.47 (0.76%)
At close: Jul 27, 2026, 4:00 PM EDT
62.54
-0.02 (-0.03%)
After-hours: Jul 27, 2026, 7:59 PM EDT

BMY Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
48,48248,19448,30045,00646,15946,385
Revenue Growth
1.78%-0.22%7.32%-2.50%-0.49%9.10%
Cost of Revenue
14,32513,93613,96810,69310,1379,940
Gross Profit
34,15734,25834,33234,31336,02236,445
Selling, General & Admin
7,3007,2678,4147,7727,8147,690
Depreciation & Amortization Expenses
2,9243,3178,8729,0479,59510,023
Research & Development
13,97113,67224,53210,21210,32411,354
Total Operating Expenses
24,19524,25641,81827,03127,73329,067
Operating Income
9,96210,002-7,4867,2828,2897,378
Total Non-Operating Income (Expense)
-367-674-8931,158-576720
Pretax Income
9,5979,328-8,3798,4407,7138,098
Provision for Income Taxes
2,3242,2725544001,3681,084
Net Income
7,2717,055-8,9338,0406,3457,014
Minority Interest in Earnings
1-----
Net Income to Common
7,2707,055-8,9338,0406,3457,014
Net Income Growth
33.71%--26.71%-9.54%-
Shares Outstanding (Basic)
2,0362,0342,0272,0692,1302,221
Shares Outstanding (Diluted)
2,0412,0392,0272,0782,1462,245
Shares Change
0.34%0.59%-2.45%-3.17%-4.41%-0.58%
EPS (Basic)
3.563.47-4.413.882.973.15
EPS (Diluted)
3.563.46-4.413.862.953.12
EPS Growth
33.33%--30.85%-5.45%-

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
11,90812,84513,94212,65111,94815,234
Free Cash Flow Growth
-9.00%-7.87%10.21%5.88%-21.57%14.55%
Free Cash Flow Per Share
5.836.306.886.095.576.79
Dividends Per Share
2.5002.4902.4202.3102.1902.010
Dividend Growth
2.46%2.89%4.76%5.48%8.96%9.24%
Gross Margin
70.45%71.08%71.08%76.24%78.04%78.57%
Operating Margin
20.55%20.75%-15.50%16.18%17.96%15.91%
Profit Margin
15.00%14.64%-18.49%17.86%13.75%15.12%
FCF Margin
24.56%26.65%28.87%28.11%25.88%32.84%
EBITDA
13,55514,0132,11417,04218,56518,064
EBITDA Margin
27.96%29.08%4.38%37.87%40.22%38.94%
EBIT
9,96210,002-7,4867,2828,2897,378
EBIT Margin
20.55%20.75%-15.50%16.18%17.96%15.91%
Effective Tax Rate
24.22%24.36%-6.61%4.74%17.74%13.39%
SEC Filings: 10-K · 10-Q